Originally developed to manage type 2 diabetes, GLP-1 receptor agonists have gained popularity for their appetite-suppressing and weight-loss effects, with the study finding that most prescriptions are now issued to women without diabetes
Semaglutide medication, commonly known as Ozempic or Wegovy, is used to treat type 2 diabetes or for weight loss
Key Takeaways Retatrutide provides triple hormone receptor activation: GLP-1, GIP, and glucagon to support blood sugar, appetite, and fat metabolism together
Sex differences in GLP-1 RA treatment response Beyond diabetes status, growing evidence also highlights the importance of sex differences in obesity, particularly regarding their impact on the effectiveness and tolerability of GLP-1 RA treatment
Do not ignore these symptoms, as they may indicate a severe allergic reaction